Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World

Mise à jour : Il y a 4 ans
Référence : NCT00703924

Femme et Homme

Extrait

This study is to determine the effectiveness and safety of WR 279,396, a topical cream for the treatment of cutaneous leishmaniasis. This study is to be conducted with a placebo control under double-blind conditions in a local population group in Tunisia where leishmaniasis is endemic.


Critère d'inclusion

  • Cutaneous Leishmaniasis

Liens